Newsroom / COVID-19 tests

In the US, use of the Mitra device is limited to research and non-diagnostic applications. In many countries outside the US, the Mitra device can be used as a sample collection device for clinical diagnostic applications, as referenced in some content.

by Neoteryx, on April 22,2021

At the end of March 2021, Quanterix Corporation issued a press release announcing that its Simoa® technology had been used in a research study to detect the SARS-CoV-2 virus. According …

Read Story

by Neoteryx, on September 23,2020

LOS ANGELES and Cambridge, UK — September 2020 — The first commercially available SARS-CoV-2 antibody test in the UK compatible with Neoteryx’s Mitra® Microsampling device for at-home blood collection has …

Read Story

by Neoteryx, on April 29,2020

“COVID-19 testing is top-of-mind for every researcher around the world at present, and effective testing is an important part of every coronavirus pandemic safety plan. Testing can potentially be done …

Read Story

The latest product releases, company news and microsampling industry updates from Neoteryx.

search our newsroom

news reporter resources:

If you don’t find the information & assets you need via the buttons below, please contact us here: press@neoteryx.com

Fact Sheet & FAQs

social media

subscribe to news